ATE447045T1 - Assoziation von proteinpolymorphismen mit koronarer herzkrankheit - Google Patents

Assoziation von proteinpolymorphismen mit koronarer herzkrankheit

Info

Publication number
ATE447045T1
ATE447045T1 AT05783566T AT05783566T ATE447045T1 AT E447045 T1 ATE447045 T1 AT E447045T1 AT 05783566 T AT05783566 T AT 05783566T AT 05783566 T AT05783566 T AT 05783566T AT E447045 T1 ATE447045 T1 AT E447045T1
Authority
AT
Austria
Prior art keywords
heart disease
coronary heart
association
protein polymorphisms
protein
Prior art date
Application number
AT05783566T
Other languages
English (en)
Inventor
Detlef Kozian
Heinz Goegelein
Karl-Ernst Siegler
Martina Jacobs
Jean-Francois Deleuze
Sylvain Ricard
Sandrine Mace
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE447045T1 publication Critical patent/ATE447045T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05783566T 2004-09-10 2005-08-27 Assoziation von proteinpolymorphismen mit koronarer herzkrankheit ATE447045T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04021528A EP1637612A1 (de) 2004-09-10 2004-09-10 Verband von Protein Polymorfismen zu Herzkrankheit
PCT/EP2005/009270 WO2006027128A1 (en) 2004-09-10 2005-08-27 Association of protein polymorphisms with coronary heart disease

Publications (1)

Publication Number Publication Date
ATE447045T1 true ATE447045T1 (de) 2009-11-15

Family

ID=34926489

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05783566T ATE447045T1 (de) 2004-09-10 2005-08-27 Assoziation von proteinpolymorphismen mit koronarer herzkrankheit

Country Status (15)

Country Link
US (1) US20070292859A1 (de)
EP (2) EP1637612A1 (de)
JP (1) JP5376802B2 (de)
KR (1) KR101232100B1 (de)
CN (1) CN101018873B (de)
AT (1) ATE447045T1 (de)
AU (1) AU2005281927B2 (de)
BR (1) BRPI0515346A (de)
CA (1) CA2579885C (de)
DE (1) DE602005017409D1 (de)
DK (1) DK1791976T3 (de)
HK (1) HK1107709A1 (de)
IL (2) IL181554A (de)
MX (1) MX2007002589A (de)
WO (1) WO2006027128A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008134539A1 (en) 2007-04-26 2008-11-06 The Regents Of The University Of Michigan Fig4 gene mutations in neurodegeneration
US10907217B1 (en) * 2015-09-01 2021-02-02 Creighton University High resolution melt-curve analysis to identify the sequence type of E. coli

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US6027884A (en) * 1993-06-17 2000-02-22 The Research Foundation Of The State University Of New York Thermodynamics, design, and use of nucleic acid sequences
JP3661953B2 (ja) * 1995-09-18 2005-06-22 進 清野 新規なａｔｐ感受性のカリウムチャネル蛋白質とその遺伝子
GB9523497D0 (en) * 1995-11-16 1996-01-17 Ashcroft Frances Cell membrane protein and application thereof
WO2003031936A2 (en) * 2001-10-11 2003-04-17 Genacy System, method, and apparatus for submitting genetic samples and receiving genetic testing results anonymously
WO2004018701A2 (en) * 2002-08-22 2004-03-04 Perlegen Sciences, Inc. Haplotype structures of chromosome 21
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof

Also Published As

Publication number Publication date
JP2008512103A (ja) 2008-04-24
AU2005281927A1 (en) 2006-03-16
DK1791976T3 (da) 2010-03-08
IL181554A0 (en) 2007-07-04
EP1637612A1 (de) 2006-03-22
IL181554A (en) 2012-05-31
US20070292859A1 (en) 2007-12-20
CA2579885A1 (en) 2006-03-16
KR20070050473A (ko) 2007-05-15
HK1107709A1 (en) 2008-04-11
DE602005017409D1 (de) 2009-12-10
KR101232100B1 (ko) 2013-02-12
AU2005281927B2 (en) 2011-12-01
MX2007002589A (es) 2007-08-06
IL211178A (en) 2012-08-30
EP1791976B1 (de) 2009-10-28
IL211178A0 (en) 2011-04-28
JP5376802B2 (ja) 2013-12-25
BRPI0515346A (pt) 2008-07-22
EP1791976A1 (de) 2007-06-06
CN101018873B (zh) 2011-11-02
CA2579885C (en) 2014-05-06
CN101018873A (zh) 2007-08-15
WO2006027128A1 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
DE60323231D1 (de) Verkürzte tau proteine
ATE516304T1 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
EP2287618A3 (de) Verfahren zur Diagnose neurodegenerativer Erkrankungen
DE602005009769D1 (de) Assay zum Nachweis von glykiertem oder glykosyliertem Hämoglobin (HbA1c)
WO2002082075A3 (de) Verfahren zum nachweis chronisch-demenzieller erkrankungen, zugehörige peptide und nachweisreagenzien
CY1109480T1 (el) ΠΡΩΤΕΪΝΕΣ ΣΥΝΔΕΣΗΣ Gag
ATE415175T1 (de) Ace2-aktivierung zur behandlung von herz, lungen, und nierenkrankheit und bluthochdruck
WO2000043791A3 (en) Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
WO2001000661A3 (en) Carnitine carrier related protein-1
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
ATE447045T1 (de) Assoziation von proteinpolymorphismen mit koronarer herzkrankheit
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
EP2083018A3 (de) Zusammensetzungen und Verfahren mit Bezug zu STOP-1
WO2005082398A3 (en) Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells
EP1560025A3 (de) Marker spezifisch für Diabetes
ATE344325T1 (de) Neisseria lactoferrin-bindendes protein
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
ATE360094T1 (de) Tcf-1 nukleotidsequenzvariation
DE60334200D1 (de) Verfahren zur messung von neprilysinaktivität
WO2003020911A3 (en) Human schizophrenia gene
ATE397753T1 (de) Screening-verfahren für eine prophylaktische und therapeutische substanz für eine nierenerkrankung
DE60023460D1 (de) Cdna von menschlicher methylentetrahydrofolatreduktase
WO2004074446A3 (en) Parkin interacting polypeptides and methods of use
ATE417936T1 (de) Verfahren zur bestimmung des allelischen zustandes am 5'-ende des alpha-s1-kaseingens
HUP0203080A2 (hu) A PRV-1 gén és felhasználása

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties